How to Adapt Your Neurodenerative Disease Trial to the COVID-19 Pandemic

 

COVID-19 disrupted the world of clinical research. Use this infographic to learn how to get your neurodegenerative trial on solid ground again with a constructive and practical evaluation of your operations and study execution tactics.
 
 
 

Questions regarding your upcoming clinical trial?